FDA Adverse Event Other Summary report: N

ACL 1000

MDR report key: 2338411 · Received November 9, 2011

Report

Report Number
1217183-2011-00090
Event Type
Other
Date Received
November 9, 2011
Date of Event
October 20, 2011
Report Date
November 7, 2011
Manufacturer
INSTRUMENTATION LABORATORY CO.
Product Code
JPA
PMA / PMN Number
K912087
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CUSTOMER STATED THAT THEY ARE CURRENTLY USING THE SINK TO DRAIN THE WASTE COMING FROM THE ACL INSTRUMENT AND OTHER HEMATOLOGY ANALYZERS (ACT 5 DIFF AND HMX). ONCE A WEEK, THEY DRAIN THE WASTE FROM THE ACL WASTE CONTAINER INTO THE SINK AND, FOLLOW BY FLUSHING COPIOUS AMOUNT OF WATER (OPEN THE WATER FOR AT LEAST 15 MINUTES). ACCORDING TO THE (B)(6) MSDS, THE WASTE SOLUTIONS SHOULD BE SEPARATED FROM ACIDS AND HEAVY METALS BECAUSE OF RISK FOR EXPLOSION. THE KIT HAZARD CLASSIFICATION (EXCERPT): "DO NOT EMPTY INTO DRAINS". SPECIAL REQUIREMENTS: KEEP AWAY FROM ACIDS (SODIUM AZIDE REACTS STRONGLY) AND AWAY FROM CONTAMINATION WITH HEAVY METALS. SODIUM AZIDE HAS BEEN REPORTED TO FORM LEAD OR COPPER AZIDE IN LABORATORY PLUMBING WHICH MAY EXPLODE ON PERCUSSIONS. DO NOT EMPTY INTO DRAINS. OUR DISTRIBUTOR, BECKMAN COULTER, STATES THAT THEY ARE IN RECEIPT OF THE SIGNED CUSTOMER CORRECTIVE ACTION RESPONSE FROM RELATING TO SODIUM AZIDE AND THE ACL COAGULATION ANALYZERS. BASED ON THE REVIEW AND GOOD LABORATORY PRACTICE, THE PRODUCT LABELING IS CORRECT, WITH NO REMEDIAL ACTION REQUIRED.

Description of Event or Problem · 1

CUSTOMER STATED THEY HAD THEIR FACILITIES DEPT ON SITE TO FIX A LEAK IN THE PLUMBING. THERE WAS AN EXPLOSION AS THEY WERE CHANGING THE PIPES. THE PERSON CHANGING THE PIPES GOT HURT AND HAD TO BE ATTENDED BY A SPECIALISTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACL 1000 COAGULATION INSTRUMENT JPA INSTRUMENTATION LABORATORY CO. ACL 1000 NA

Patients

Seq Age Sex Outcome Treatment
1